Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11) - Image 1

£99.87

Springer Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

Name: Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)
Brand: Springer
Price: 99.87 GBP
Availability: InStock

General Medical Issues

Price History & Forecast

Last 12 days • 12 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 12 days • 1 price levels

Days at Price

Price Analysis

Most common price: £100 (12 days, 100.0%)

Price range: £100 - £100

Price levels: 1 different prices over 12 days

Description

This book offers comprehensive information on the new and rapidly evolving science of identifying and targeting senescent cells, and on the exciting prospect of new diagnostic and therapeutic opportunities for stopping, and even reversing, the progression of disease and the deterioration of the human body due to ageing. According to recent United Nations data, by 2050 one in six people worldwide will be older than age 65, with peaks rising to one in four people in Europe and North America. Remarkably, the number of persons aged 80 years or older is expected to triple, from 143 million in 2019 to 426 million in 2050. First documented in the 1960s, the concept of cellular senescence as an underlying cause of ageing has been established in the course of the last decade. Using genetically engineered mouse models, researchers have demonstrated that the selective elimination of senescent cells can block and even reverse a number of age-related dysfunctions and pathologies, promoting both better health and longer life in the elderly. These include cardiovascular diseases; neurological disorders; type 1 and type 2 diabetes; inflammatory diseases; fibrosis; geriatric syndromes; chronic diseases resulting in organ dysfunction; the integrity of the musculoskeletal system; and cancer. Some senolytic agents have already progressed into trials. These include UBX0101 for the treatment of osteoarthritis (now in phase II), a cocktail of dasatinib and quercetin for the management of idiopathic pulmonary fibrosis and chronic kidney disease, and ABT-263 in combination with senescence-inducing chemotherapies for the treatment of advanced solid tumours. In addition, the book discusses pathways to early phase clinical trials and translational approaches in medicine and ageing, highlighting new opportunities as well as current limitations, challenges and alternatives. Given its scope, it will benefit a broad audience of advanced educators, researchers, graduate students and practitioners.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3030449025
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 28 April 2020
Listed Since: 03 March 2020

Barcode

No barcode data available

Springer Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Senolytics in Disease, Ageing and Longevity: 11 (Healthy Ageing and Longevity, 11)

Cellular Senescence in Disease

Reviews on New Drug Targets in Age-Related Disorders: 1260 (Advances in Experimental Medicine and Biology, 1260)

The Biology of Senescence: A Translational Approach (Practical Issues in Geriatrics)

Springer Reviews on New Drug Targets in Age-Related Disorders

Springer - Molecular Basis and Emerging Strategies for Anti-aging

Redox Signaling and Biomarkers in Ageing: 15 (Healthy Ageing and Longevity, 15)

Springer - Topics in Biomedical Gerontology Research Book

Topics in Biomedical Gerontology

Encyclopedia of Biomedical Gerontology

Redox Signaling and Biomarkers in Ageing: 15 (Healthy Ageing and Longevity, 15)

Nutrients and Nutraceuticals for Active & Healthy Ageing

Evolutionary Gerontology and Geriatrics: Why and How We Age: 2 (Advances in Studies of Aging and Health, 2)

Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing

Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing

The Future of Aging: Pathways to Human Life Extension

Senescence Back and Forth

Humana Microbiology and Aging: Clinical Manifestations Book

Emerging Anti-Aging Strategies

Clinical Genetics and Genomics of Aging

Springer Exosomes, Stem Cells and MicroRNA - Volume 1056

Cellular Aging: 14 (Modern Cell Biology)

Plant Bioactives as Natural Panacea against Age-Induced Diseases: Nutraceuticals and Functional Lead Compounds for Drug Development (Drug Discovery Update)

Aging And Age-related Diseases: The Basics